Feasibility of ultra high field 7.0 Tesla MRI for the detection of breast cancer

Feasibility of ultra high field 7.0 Tesla MRI for the detection of breast cancer - 7T breast MRI study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34075

Enrollment

Registered

2010-07-20

Start date

2010-10-14

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer breast neoplasm

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years or older - Female patients - A breast lesion

Exclusion criteria

Exclusion criteria: - Any prior surgery or radiotherapy to the ipsilateral breast - Karnofsky score

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the 7T detection rate of stage T1 breast cancer lesions.	—

Secondary

Measure	Time frame
- To assess the morphology of the cancer lesions as described in the MRI BI-RADS lexicon. - To assess the kinetics of lesion enhancement. - To assess the correlation of 7T MRI analysed lesions sizes to the sizes as determined in the final pathological analysis.	—

Countries

Netherlands

Outcome results